PIF4 protein level regulates <i>PIF4</i> promoter activity in a temperature-dependent manner. by Sreya Das (20531295)

Subjects:

Estimated marginal mean values representative of the average time on ball and the relative frequency of ball touches and releases per minute of match duration, performed by profess... by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”

Safranin O fast green staining results of cartilage tissue in different groups of rat PTOA (A: normal group, B: mild PTOA group, C: severe PTOA group). by Peng-fei Han (694841)

Subjects:

ST2+ KLRG-1+ Tregs from <i>T</i>. <i>cruzi</i> infected mice exhibit a phenotype compatible with <i>bona fide</i> trTregs. by Santiago Boccardo (5927954)

Subjects:

Maximum voluntary contraction assessment. by María Benito-de-Pedro (22057468)

Subjects:

Neural tracking of speech across linguistic timescales in relation to cognitive decline and hearing ability. by Elena Bolt (20396190)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Responses to speech onset and target nouns in relation to cognitive decline and context. by Elena Bolt (20396190)

Subjects:

Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model. by Ze-Xing Zhang (18074512)

Subjects:

MoCA scores distribution and audiometry results for participants. by Elena Bolt (20396190)

Subjects:

Contribution of changes in population aging, population growth, and age-specific incidence rate to changes in incident cases of LC from 2004 to 2018 in China. by Ze-Xing Zhang (18074512)

Subjects:

Speech material modulation spectrum and behavioral speech recognition task results. by Elena Bolt (20396190)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Parapapillary choroidal microvasculature in eyes with myopia and glaucoma (inner/outer whole annulus PPCMv densities=  0.092/0.069), glaucoma without myopia (0.092/0.071), and myop... by Yanin Suwan (4752099)

Subjects:

PPI network analysis. by Du Leng (20421711)

ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined in global in 2021. by Nannan Qian (10650782)

Subjects:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”